Skip to content

To Compare The Efficacy Of Application Of Moolaka Alkali And Apamarga Alkali In Inferior Turbinate Hypertrophy

An Open Label Double Arm Randomised Clinical Study To Compare The Efficacy Of Moolaka Pratisaraneeya Kshara And Apamarga Pratisaraneeya Kshara In The Management Of Nasanaha Wsr To Inferior Turbinate Hypertrophy - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086992
Enrollment
40
Registered
2025-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J343- Hypertrophy of nasal turbinates

Interventions

None listed

Sponsors

Dr Bindushree s b
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with lakshanas of Nasanaha Subjects with inferior turbinate hypertrophy Subjects of either gender between 20 to 60 years of age Subjects fit for kshara karma

Exclusion criteria

Exclusion criteria: Subjects with history of Atrophic rhinitis Nasal polyps Epistaxis and history of Benign and Malignant nasal and paranasal tumours Pregnant and lactating mother Subjects presenting with systemic diseases that may interfere with the course of treatment

Design outcomes

Primary

MeasureTime frame
to check the reduction of size of inferior turbinate hypertrophy using compass caliper nose score and friedman grading system of inferior turbinate hyper trophy through anterior rhinoscopy and other parameters in two treatment modalities viz moolaka pratisaraneeya kshara ans apamarga pratisaraneeya kshara in nasanaha w s r to inferior turbinate hypertrophyTimepoint: 11day of study 1 day application, 3rd and 7 th day follow up

Secondary

MeasureTime frame
nilTimepoint: not applicable

Countries

India

Contacts

Public ContactDr Hamsaveni v

shri kalabyraveshwaraswamy ayurvedic medical college and research center

vimalbut@gmail.com9900110912

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026